Free Trial

Clarivate (CLVT) Competitors

Clarivate logo
$4.00 -0.08 (-1.96%)
Closing price 03/26/2025 03:58 PM Eastern
Extended Trading
$4.00 0.00 (-0.12%)
As of 03/26/2025 06:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CLVT vs. RTO, ALLE, FTAI, CART, ULS, MEDP, STN, BILI, HQY, and WPP

Should you be buying Clarivate stock or one of its competitors? The main competitors of Clarivate include Rentokil Initial (RTO), Allegion (ALLE), FTAI Aviation (FTAI), Maplebear (CART), UL Solutions (ULS), Medpace (MEDP), Stantec (STN), Bilibili (BILI), HealthEquity (HQY), and WPP (WPP). These companies are all part of the "business services" industry.

Clarivate vs.

Clarivate (NYSE:CLVT) and Rentokil Initial (NYSE:RTO) are both computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, valuation, institutional ownership, dividends, community ranking, analyst recommendations and profitability.

Rentokil Initial has higher revenue and earnings than Clarivate. Clarivate is trading at a lower price-to-earnings ratio than Rentokil Initial, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clarivate$2.56B1.08-$911.20M-$0.96-4.17
Rentokil Initial$5.44B2.13$473.93M$1.5115.18

Rentokil Initial has a net margin of 0.00% compared to Clarivate's net margin of -24.90%. Clarivate's return on equity of 9.10% beat Rentokil Initial's return on equity.

Company Net Margins Return on Equity Return on Assets
Clarivate-24.90% 9.10% 3.93%
Rentokil Initial N/A N/A N/A

Clarivate presently has a consensus price target of $5.83, suggesting a potential upside of 45.83%. Given Clarivate's higher possible upside, equities research analysts clearly believe Clarivate is more favorable than Rentokil Initial.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Clarivate
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Rentokil Initial
0 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.71

Clarivate has a beta of 1.28, indicating that its stock price is 28% more volatile than the S&P 500. Comparatively, Rentokil Initial has a beta of 1.14, indicating that its stock price is 14% more volatile than the S&P 500.

85.7% of Clarivate shares are owned by institutional investors. Comparatively, 9.9% of Rentokil Initial shares are owned by institutional investors. 23.1% of Clarivate shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Clarivate and Clarivate both had 6 articles in the media. Rentokil Initial's average media sentiment score of 1.50 beat Clarivate's score of 1.13 indicating that Rentokil Initial is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Clarivate
3 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Rentokil Initial
5 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Clarivate received 43 more outperform votes than Rentokil Initial when rated by MarketBeat users. Likewise, 53.33% of users gave Clarivate an outperform vote while only 35.71% of users gave Rentokil Initial an outperform vote.

CompanyUnderperformOutperform
ClarivateOutperform Votes
48
53.33%
Underperform Votes
42
46.67%
Rentokil InitialOutperform Votes
5
35.71%
Underperform Votes
9
64.29%

Summary

Rentokil Initial beats Clarivate on 9 of the 17 factors compared between the two stocks.

Remove Ads
Get Clarivate News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLVT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CLVT vs. The Competition

MetricClarivateData processing & preparation IndustryComputer SectorNYSE Exchange
Market Cap$2.76B$3.96B$23.72B$19.67B
Dividend YieldN/A3.51%2.81%3.75%
P/E Ratio-4.1767.5842.7233.83
Price / Sales1.08705.832,051.9628.00
Price / Cash2.8933.7434.6517.54
Price / Book0.546.046.294.60
Net Income-$911.20M$42.75M$736.56M$1.02B
7 Day Performance-8.99%-0.15%-0.53%-0.38%
1 Month Performance-12.09%-5.05%49,591.31%-2.84%
1 Year Performance-45.50%11.29%52,625.95%6.61%

Clarivate Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLVT
Clarivate
3.0565 of 5 stars
$4.00
-2.0%
$5.83
+45.8%
-45.5%$2.76B$2.56B-4.1711,600Positive News
RTO
Rentokil Initial
3.029 of 5 stars
$22.18
+1.4%
N/A-23.6%$11.20B$5.44B14.6962,900Short Interest ↓
Positive News
ALLE
Allegion
4.3477 of 5 stars
$127.42
+0.6%
$138.33
+8.6%
-2.2%$10.99B$3.77B18.6811,000Analyst Forecast
Positive News
FTAI
FTAI Aviation
4.1051 of 5 stars
$106.98
+2.6%
$173.67
+62.3%
+70.9%$10.97B$1.73B-1,069.6940Positive News
CART
Maplebear
4.2987 of 5 stars
$40.64
+5.4%
$50.52
+24.3%
+10.4%$10.76B$3.38B27.283,380Positive News
ULS
UL Solutions
1.8955 of 5 stars
$52.34
+0.2%
$51.45
-1.7%
N/A$10.48B$2.87B32.3115,233Positive News
MEDP
Medpace
4.4328 of 5 stars
$326.34
+0.4%
$381.44
+16.9%
-21.1%$9.94B$2.11B25.845,900Analyst Upgrade
Short Interest ↓
Analyst Revision
News Coverage
Positive News
STN
Stantec
3.0536 of 5 stars
$83.63
+1.4%
N/A-0.8%$9.54B$7.50B38.0128,000Positive News
BILI
Bilibili
1.9226 of 5 stars
$22.28
+3.9%
$21.11
-5.3%
+85.7%$9.23B$26.83B-49.5112,300Short Interest ↓
Positive News
HQY
HealthEquity
3.6334 of 5 stars
$100.72
+3.4%
$112.92
+12.1%
+12.3%$8.73B$1.15B92.403,150Analyst Forecast
WPP
WPP
3.4179 of 5 stars
$40.27
+1.0%
N/A-16.1%$8.69B$14.74B6.75114,732Analyst Forecast
Short Interest ↓
Remove Ads

Related Companies and Tools


This page (NYSE:CLVT) was last updated on 3/27/2025 by MarketBeat.com Staff
From Our Partners